Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study

(2019) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use

(2019) Marco Proietti et al.   MAYO CLINIC PROCEEDINGS

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

(2018) Dipak Kotecha et al.   EUROPACE

Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries

(2018) Marco Proietti et al.   European Journal of Internal Medicine

Catheter Ablation for Atrial Fibrillation with Heart Failure

(2018) Nassir F. Marrouche et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway

(2018) Marco Proietti et al.   AMERICAN JOURNAL OF MEDICINE

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

(2018) Karen P. Alexander et al.   AMERICAN HEART JOURNAL

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events

(2018) Daniele Pastori et al.   MAYO CLINIC PROCEEDINGS

Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision

(2018) Marco Proietti et al.   THROMBOSIS AND HAEMOSTASIS

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort

(2017) Bhautesh Dinesh Jani et al.   EUROPACE

The future of atrial fibrillation management: integrated care and stratified therapy

(2017) Paulus Kirchhof   LANCET

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Causes of Death and Influencing Factors in Patients with Atrial Fibrillation

(2016) Laurent Fauchier et al.   AMERICAN JOURNAL OF MEDICINE

Causes of Death in Anticoagulated Patients With Atrial Fibrillation

(2016) Antonio Gómez-Outes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

(2016) Jeroen Jaspers Focks et al.   BMJ-British Medical Journal

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

(2016) Jeroen Jaspers Focks et al.   BMJ-British Medical Journal

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationCLINICAL PERSPECTIVE

(2015) Jonathan P. Piccini et al.   CIRCULATION

Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial

(2015) Marco Proietti et al.   Clinical Research in Cardiology

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

(2014) Benjamin A. Steinberg et al.   AMERICAN HEART JOURNAL

Causes of Death and Influencing Factors in Patients With Atrial Fibrillation

(2013) Eloi Marijon et al.   CIRCULATION